For poorly differentiated breast tumors, an increase in the content of IL-1β, IL-2, IL-6, and IL-10 was observed, while the content of the rest decreased compared to the control group, but to a lesser extent than for highly differentiated tumors. The gene discussed is IL1B; the disease is breast neoplasm.